Aevi Genomic Medicine: 2Q Earnings Snapshot
WAYNE, Pa. (AP) _ Aevi Genomic Medicine Inc. (GNMX) on Thursday reported a loss of $8.2 million in its second quarter.
On a per-share basis, the Wayne, Pennsylvania-based company said it had a loss of 14 cents.
The company’s shares closed at $1.10. A year ago, they were trading at $1.20.